Surgery Partners Inc (SGRY) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Surgery Partners Inc (SGRY) has a cash flow conversion efficiency ratio of 0.024x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($83.60 Million) by net assets ($3.55 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Surgery Partners Inc (SGRY) balance sheet quality index to measure how much of total assets are equity-financed.
Surgery Partners Inc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Surgery Partners Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Surgery Partners Inc (SGRY) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Surgery Partners Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Surgery Partners Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China Eastern Airlines Corporation Limited
F:CIAH
|
0.231x |
|
Entra ASA
OL:ENTRA
|
0.054x |
|
China Science Publishing & Media Ltd
SHG:601858
|
0.023x |
|
Shandong Shida Shenghua Chem
SHG:603026
|
0.029x |
|
Changshu Tianyin Electromechan
SHE:300342
|
0.028x |
|
Shenzhen Airport Co Ltd
SHE:000089
|
0.037x |
|
Grupo Bafar S.A.B. de C.V
MX:BAFARB
|
0.056x |
|
Hyundai Mar&Fi
KO:001450
|
0.272x |
Annual Cash Flow Conversion Efficiency for Surgery Partners Inc (2013–2024)
The table below shows the annual cash flow conversion efficiency of Surgery Partners Inc from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Surgery Partners Inc (SGRY) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $3.64 Billion | $300.10 Million | 0.083x | -5.54% |
| 2023-12-31 | $3.36 Billion | $293.80 Million | 0.087x | +80.67% |
| 2022-12-31 | $3.28 Billion | $158.80 Million | 0.048x | +27.72% |
| 2021-12-31 | $2.30 Billion | $87.10 Million | 0.038x | -75.10% |
| 2020-12-31 | $1.62 Billion | $246.90 Million | 0.152x | +99.58% |
| 2019-12-31 | $1.70 Billion | $129.50 Million | 0.076x | -- |
| 2018-12-31 | $0.00 | $144.60 Million | x | -- |
| 2017-12-31 | $0.00 | $120.94 Million | x | -- |
| 2016-12-31 | $0.00 | $125.24 Million | x | -- |
| 2015-12-31 | $0.00 | $84.48 Million | x | -- |
| 2014-12-31 | $222.12 Million | $21.95 Million | 0.099x | +102.89% |
| 2013-12-31 | $-14.38 Million | $49.08 Million | -3.414x | -- |
About Surgery Partners Inc
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers … Read more